JC virus detection and JC virus-specific immunity in natalizumab-treated Multiple Sclerosis patients

摘要

BackgroundThe use of natalizumab in multiple sclerosis (MS) may favour JC virus reactivation; this phenomenon is usually asymptomatic but can, albeit rarely, evolve into frank progressive multifocal leucoencephalopathy (PML).